Article
AXL Knock-Out in SNU475 Hepatocellular Carcinoma Cells Provides Evidence for Lethal Effect Associated with G2 Arrest and Polyploidization.
International journal of molecular sciences - 9 Dec 2021
Batur Tugce, Argundogan Ayse, Keles Umur, Mutlu Zeynep, Alotaibi Hani, Senturk Serif, Ozturk Mehmet
Abstract excerpt
AXL, a member of the TAM family, is a promising therapeutic target due to its elevated expression in advanced hepatocellular carcinoma (HCC), particularly in association with acquired drug resistance. Previously, RNA interference was used to study its role in cancer, and several phenotypic changes, including attenuated cell proliferation and decreased migration and invasion, have been reported. The mechanism of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
